← Back to Search

Family Service Navigation for Autism

N/A

Recruiting

Led By Meghan Burke, PhD

Research Sponsored by Vanderbilt University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be age 18 or older,

Be English speaking or Spanish-speaking,

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at the pre-survey and at the three-month, six-month, and nine-month survey

Awards & highlights

No Placebo-Only Group

Summary

This trialtests a training program and app to help families of young kids (3-5) with autism access needed services.

Who is the study for?

This trial is for English-speaking parents, aged 18 or older, from low-resourced communities. They must have a young child (aged 3-5) with autism and want help navigating service systems. Participants need to own or be provided a phone compatible with the treatment support app.

What is being tested?

The study is evaluating a program where trained Family Service Navigators use an app to assist families in accessing services for children with autism. It aims to see if this support improves service access for these families.

What are the potential side effects?

Since this trial involves educational and technological interventions rather than medical treatments, traditional physical side effects are not expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I speak English or Spanish.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at the pre-survey and at the nine-month survey

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at the pre-survey and at the nine-month survey

This trial's timeline: 3 weeks for screening, Varies for treatment, and at the pre-survey and at the nine-month survey for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Adaptive and maladaptive behavior at 9 months

Change in Advocacy at 9 months

Change in Empowerment at 9 months

+5 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention Group (Access to an FSN/TSS)Experimental Treatment1 Intervention

40 participants will be randomly assigned to the intervention group (i.e., to receive an FSN and have access to the TSS). The FSN may meet with the participant at least twice and provide navigation support.

Group II: Control Group (Access to Information, training and referral)Active Control1 Intervention

15 participants will be randomly assigned to the non-personalized comparison group (i.e., information, training, and referral).

0 / 2Eligibility criteria met